|
JAMA Oncology |
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Asymptomatic Cutaneous Plaques on the Scalp and Face in an Older Adult Woman |
1 |
Yes |
7/21/2025 |
|
JAMA Oncology |
Global Association of COVID-19 Pandemic Measures With Cancer Screening - A Systematic Review and Meta-analysis |
1 |
Yes |
8/1/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular Carcinoma |
1 |
Yes |
9/22/2025 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 |
1 |
Yes |
10/26/2025 |
|
JAMA Oncology |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic |
1 |
Yes |
11/7/2025 |
